Veeva Looks To EU MDR As Spur For Medtech Innovation
Executive Summary
Cloud-based software company Veeva Systems is optimistic the new EU Medical Device Regulation will encourage innovation over time. Veeva executives Seth Goldenberg and Annemien Pullen sat down with Medtech Insight to share their perspectives on how EU MDR could impact the sector.
You may also be interested in...
Goldman Sachs Takes Holding In CRO Aragen Amid Outsourcing Impetus
Goldman Sachs backs CRO Aragen, which it believes is well placed to gain from the “secular trend” of an outsourcing uptick by biopharma. Aragen has a string of alliances and is also assisting with both vaccine and test kit development against SARS-CoV-2 for its customers.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.